These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23524144)

  • 1. A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells.
    Jin FZ; Yu C; Zhao DZ; Wu MJ; Yang Z
    Exp Cell Res; 2013 Jun; 319(10):1482-90. PubMed ID: 23524144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
    Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
    Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway.
    Niu Y; Xia Y; Wang J; Shi X
    Mol Med Rep; 2017 Apr; 15(4):2083-2089. PubMed ID: 28259907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
    Harosh-Davidovich SB; Khalaila I
    Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
    Sermikli BP; Aydogdu G; Yilmaz E
    Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyper-O-GlcNAcylation inhibits the induction of heat shock protein 70 (Hsp 70) by sodium arsenite in HeLa cells.
    Miura Y; Sato T; Sakurai Y; Sakai R; Hiraoka W; Endo T
    Biol Pharm Bull; 2014; 37(8):1308-14. PubMed ID: 25087952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.
    Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S
    J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.
    Huang H; Wu Q; Guo X; Huang T; Xie X; Wang L; Liu Y; Shi L; Li W; Zhang J; Liu Y
    J Cell Physiol; 2021 Nov; 236(11):7491-7503. PubMed ID: 33843053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
    Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
    Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP).
    Jacobsen KT; Iverfeldt K
    Biochem Biophys Res Commun; 2011 Jan; 404(3):882-6. PubMed ID: 21182826
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Xu Z; Isaji T; Fukuda T; Wang Y; Gu J
    J Biol Chem; 2019 Mar; 294(9):3117-3124. PubMed ID: 30587575
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of O-GlcNAcylation Regulates Autophagy in Cortical Astrocytes.
    Rahman MA; Hwang H; Cho Y; Rhim H
    Oxid Med Cell Longev; 2019; 2019():6279313. PubMed ID: 31827688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.
    Kanwal S; Fardini Y; Pagesy P; N'tumba-Byn T; Pierre-Eugène C; Masson E; Hampe C; Issad T
    PLoS One; 2013; 8(7):e69150. PubMed ID: 23935944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between cellular O-GlcNAcylation and sensitivity to O-GlcNAc inhibitor in colorectal cancer cells.
    Wongprayoon P; Pengnam S; Srisuphan R; Opanasopit P; Jirawatnotai S; Charoensuksai P
    PLoS One; 2024; 19(10):e0312173. PubMed ID: 39413067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
    Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome.
    Zuliani I; Lanzillotta C; Tramutola A; Francioso A; Pagnotta S; Barone E; Perluigi M; Di Domenico F
    Neurotherapeutics; 2021 Jan; 18(1):340-363. PubMed ID: 33258073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.